Abstract
Two sensitive and selective chromatographic methods were developed and validated for determination of veralipride in presence of its degradation products. Forced degradation studies were performed, using HCl, NaOH and 3% H2O2. The first method is based on thin-layer chromatographic separation of the intact drug spot from its degradation, followed by densitometric measurements. The second method is based on isocratic liquid chromatographic separation of the studied drug from its degradation on a reversed phase C18 column. The proposed LC method was utilized to investigate the kinetics of alkaline degradation process of the selected drug at different temperatures.
References
Martindale (2007) The complete drug reference, 35th edn. The pharmaceutical press, London, 1736
Michele R, Antonella A (2005) J Neuropsychiatry Clin Neurosci. 17:252–253, PMID 15939983
Vincenzo DL, Giuseppe M, Maria CM, Elisa F, Ada D, Felice P (2006) Expert Opin Drug Saf 5:695–701. doi:10.1517/14740338.5.5.695
The Merck Index (2006) 14th edn. Merck and Co. Inc., Whitehouse Station, pp 1710
Staveris S, Jung L, Gamet G, Koffel JC (1985) J Chromatogr 338:79–88
ICH Q2A (1994) Validation of analytical methods: definitions and terminology. In: IFPMA (ed) International Conference on Harmonization, Geneva
ICH Q2B (1996) Validation of analytical procedure: methodology. In: IFPMA (ed) International Conferences on Harmonization, Geneva
Clark’s (2004) Analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material, third edition. Pharmaceutical Press, London, p 293
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salem, M.Y., Salama, N.N.E.D., Halim, L.M.A.E. et al. Validated Stability-Indicating Chromatographic Methods for the Determination of Veralipride in Presence of Its Degradation Products. Chroma 70, 1299–1302 (2009). https://doi.org/10.1365/s10337-009-1302-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-009-1302-x